GoHealth (NASDAQ:GOCO - Get Free Report) will be issuing its quarterly earnings data before the market opens on Thursday, November 7th. Analysts expect the company to announce earnings of ($3.19) per share for the quarter. Individual that are interested in registering for the company's earnings conference call can do so using this link.
GoHealth (NASDAQ:GOCO - Get Free Report) last issued its quarterly earnings data on Thursday, August 8th. The company reported ($0.75) EPS for the quarter, topping analysts' consensus estimates of ($2.47) by $1.72. GoHealth had a negative return on equity of 8.51% and a negative net margin of 8.62%. The company had revenue of $105.87 million for the quarter, compared to analysts' expectations of $138.99 million. On average, analysts expect GoHealth to post $-5 EPS for the current fiscal year and $-4 EPS for the next fiscal year.
GoHealth Stock Down 2.3 %
Shares of GOCO stock traded down $0.27 during trading hours on Thursday, reaching $11.34. The company had a trading volume of 17,349 shares, compared to its average volume of 17,774. The company has a market capitalization of $258.99 million, a P/E ratio of -1.58 and a beta of 1.71. The company has a debt-to-equity ratio of 1.83, a quick ratio of 1.29 and a current ratio of 1.29. GoHealth has a twelve month low of $7.27 and a twelve month high of $16.44. The stock's fifty day simple moving average is $9.37 and its 200 day simple moving average is $10.01.
Wall Street Analysts Forecast Growth
Separately, Royal Bank of Canada restated a "sector perform" rating and issued a $13.00 target price on shares of GoHealth in a research note on Monday, October 21st.
Check Out Our Latest Analysis on GOCO
About GoHealth
(
Get Free Report)
GoHealth, Inc operates as a health insurance marketplace and Medicare-focused digital health company in the United States. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs.
See Also
Before you consider GoHealth, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GoHealth wasn't on the list.
While GoHealth currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
